| Financial Year |
March 31 2023 |
| Monetary Funds |
420,204,032.45 |
| Held-for-trading Financial Assets |
50,588,345.29 |
| Notes Receivable |
13,856,290.22 |
| Accounts Receivable |
132,156,487.30 |
| Advances to Suppliers |
67,670,100.31 |
| Other Receivables |
5,132,589.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
259,413,958.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
117,827,499.90 |
| Total Current Assets |
1,107,940,131.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
36,926,835.85 |
| Investment Properties |
-- |
| Fixed Assetes |
723,121,002.79 |
| Under-construction Projects |
59,652,906.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,158,169.08 |
| R&D expenses |
-- |
| Goodwill |
366,482.57 |
| Long-Term Deferred and Prepaid Expenses |
3,637,417.20 |
| Deferred Income Tax Assets |
13,189,312.68 |
| Other Non-Current Assets |
29,148,085.80 |
| Sub-Total of Non-Current Assets |
931,086,232.88 |
| Total Assets |
2,039,026,364.64 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
81,830,061.83 |
| Accounts Payable |
148,623,509.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
750,870.16 |
| Taxes Payable |
2,728,121.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,264,757.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,855,218.44 |
| Other Current Liabilities |
2,979,819.58 |
| Sub-Total of Current Liabilities |
410,108,074.31 |
| Long-term Loans |
30,000,000.00 |
| Bonds Payable |
311,276,811.11 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,440,947.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
395,187,483.67 |
| Total Liabilities |
805,295,557.98 |
| Paid-In Capital(Or Share Stock) |
105,009,368.00 |
| Capital Surplus |
292,878,484.72 |
| Surplus Reserve |
82,786,132.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
642,879,497.68 |
| Minority Stockholder's Interest |
8,369,830.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,225,360,975.84 |
| Owner's Equity（Stockholder's Equity） |
1,233,730,806.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,039,026,364.64 |
